Salona Global Completes Turn Around Plan with Profitable Third Quarter, Posting Record Results with 18.5% Quarterly Organic Revenue Growth and 29% Quarterly Gross Profit Growth; Generates $749,425 in Adjusted EBITDA for the Quarter

Stock Information for Salona Global Medical Device Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Salona Global Medical Device Corporation

Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors
Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company
Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component
Salona Global Announces the Debut of the Biodex SpaceTek Knee(TM), a Revolutionary Portable Isokinetic Knee Dynamometer Medical Device Developed in NASA Collaboration
Salona Global Showcases Biodex Products at Medica Trade Fair in Düsseldorf, Germany; Expanding Access to International Markets
Salona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish Market
Salona Global Announces Plans to Change Name to Evome Medical Technologies Inc.; Confirms Positive Adjusted EBITDA and Net Profit for Q3 2023; Appoints New CFO
Salona Global Announces Expansion of Bank Line

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.